Hopewell Therapeutics

Hopewell Therapeutics is a biotechnology company. The company is designing systemically administered LNPs, specifically targeting extrahepatic tissues and cells throughout the body. Hopewell has built an intellectual property portfolio with a vast library of ionizable lipids and established partnerships with several industry-leading companies. Hopewell is developing its internal pipeline, initially focused on pulmonary diseases, while exploring the potential of its ttLNP platform to address unmet needs in patients with oncology, infectious diseases, rare genetic disorders, and neurological conditions.